Related Experiment Video
Updated: May 31, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-129-3p Suppresses Tumor Progression and Chemoradioresistance in Head and Neck Squamous Cell Carcinoma
Tae Mi Yoon1, Sun-Ae Kim1, Eun Kyung Jung1
1Departments of Otorhinolaryngology-Head and Neck Surgery, Chonnam National University Medical School, Hwasun Hospital, Hwasun 58128, Jeonnam, Republic of Korea.
Abstract:
(1) Background: MicroRNA-129 (miR-129) participates in tumor progression and chemoresistance in various cancer types. In this study, the role of miR-129-3p, the main mature form of miR-129, in tumor progression and chemoradiotherapy resistance in head and neck cancer was evaluated. (2) Methods: RT-PCR, western blotting, cell proliferation assays, cell apoptosis assays, and cell invasion and migration assays were used. (3) Results: In this study, the miR-129-3p overexpression suppressed the proliferation, invasion, and migration of SNU1041, SCC15, and SCC25 human HNSCC cell lines. Additionally, it induced apoptosis and enhanced radiation-/cisplatin-induced apoptosis of SNU1041, SCC15, and SCC25 cells. Therefore, miR-129-3p could suppress tumor progression and enhance chemoradiosensitivity in human HNSCC. Furthermore, miR-129-3p was downregulated in fresh tumor tissues from patients with HNSCC compared with that in the adjacent normal mucosa. In a nude mouse xenograft model with SNU15 cells, the miR-129-3p overexpression significantly decreased tumor growth, as measured by tumor weight and volume. (4) Conclusions: Our study provides evidence that miR-129-3p suppresses tumor progression and chemoradioresistance in HNSCC. This finding may serve as a basis for developing miR-129-3p-based therapeutic strategies.
Insights
MicroRNA-129-3p (miR-129-3p) suppresses head and neck cancer progression and enhances chemoradiotherapy resistance. This microRNA was found to be downregulated in patient tumors, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-129 (miR-129) is implicated in cancer progression and chemoresistance.
- miR-129-3p is the primary mature form of miR-129.
- Its role in head and neck squamous cell carcinoma (HNSCC) progression and treatment resistance requires investigation.
Purpose of the Study:
- To evaluate the function of miR-129-3p in HNSCC tumor progression.
- To assess the impact of miR-129-3p on chemoradiotherapy resistance in HNSCC.
- To determine miR-129-3p expression levels in HNSCC tissues.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-PCR) for gene expression analysis.
- Western blotting to assess protein levels.
- Cellular assays including proliferation, apoptosis, invasion, and migration.
- In vivo studies using a nude mouse xenograft model.
Main Results:
- Overexpression of miR-129-3p inhibited proliferation, invasion, and migration in HNSCC cell lines (SNU1041, SCC15, SCC25).
- miR-129-3p induction enhanced apoptosis and sensitized HNSCC cells to radiation and cisplatin treatment.
- Tumor tissues from HNSCC patients showed lower miR-129-3p levels compared to normal adjacent tissues.
- In vivo, miR-129-3p overexpression significantly reduced tumor growth in a xenograft model.
Conclusions:
- miR-129-3p acts as a tumor suppressor in HNSCC.
- miR-129-3p enhances sensitivity to chemoradiotherapy in HNSCC.
- These findings support the development of miR-129-3p-based therapeutic strategies for HNSCC.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
Experimental RNAi
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

